Vital Images Inc. recently introduced the VioSuite Image Management and Vitality Solutions Business Intelligence product families, providing healthcare administrators with a robust set of tools to improve system-wide image access and image data analytics. VioSuite and Vitality Solutions, as well as the company’s flagship products VitreaAdvanced and VitreaView software, were showcased at the 9th annual Health Information and Management Systems Society (HIMSS) Asia Pacific Conference and Exhibition.

September 14, 2015 — Healthcare providers can assess a patient’s risk of sudden cardiac death (SCD) following a percutaneous coronary intervention (PCI) using a new point-of-care post-PCI risk calculator available for download at SCDFacts.org and in the iTunes or Android app stores.

The assessment is based on the 10 most clinically relevant SCD mortality risk factors, as identified and supported by numerous peer-reviewed articles and studies.  

New Haven Pharmaceuticals Inc. announced U.S. Food and Drug Administration (FDA) approval of Durlaza (aspirin) 24-hour extended-release capsules for the secondary prevention of stroke and acute cardiac events, including myocardial infarction.

Zevacor Molecular (Zevacor), manufacturer and distributor of positron emission tomography (PET) and single photon emission computed tomography (SPECT) radiopharmaceuticals, announced the arrival of a 70 MeV Cyclotron at its new production facility in Noblesville, Indiana.

Westinghouse Electric Company and NorthStar Medical Radioisotopes announced a memorandum of understanding to explore producing medical radioisotopes from the core of commercial nuclear reactors, and methods of global distribution. The exploration involves generating the most widely used radioisotope in medical diagnostic imaging by treating an isotope of the chemical element molybdenum rather than enriched uranium.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now